政府更多干预处方药定价的好处

{"title":"政府更多干预处方药定价的好处","authors":"Ryan S. Houser","doi":"10.1016/j.hpopen.2022.100071","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":34527,"journal":{"name":"Health Policy Open","volume":"3 ","pages":"Article 100071"},"PeriodicalIF":2.3000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297769/pdf/","citationCount":"0","resultStr":"{\"title\":\"The benefits of more government interference in prescription drug pricing\",\"authors\":\"Ryan S. Houser\",\"doi\":\"10.1016/j.hpopen.2022.100071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":34527,\"journal\":{\"name\":\"Health Policy Open\",\"volume\":\"3 \",\"pages\":\"Article 100071\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297769/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Policy Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590229622000065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590229622000065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}